Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MQB Partners is an active global healthtech investment management firm based in Wellington, New Zealand. The team comprises experienced investors and entrepreneurs from healthcare and technology sectors with expertise spanning gene therapy, molecular medicine, neuroscience, biochemistry, digital health, medical devices, biotechnology, surgery and clinical medicine. They invest globally in innovative healthtech companies across medical devices, digital health solutions, drug/biologic product development and diagnostics. Their recent investments include participation in Cerevance’s $47M Series B round (April 2024), supporting CNS disease therapeutics development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MQB Partners.